Hypoplastic Left Heart Syndrome Clinical Trial
Official title:
Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure
Verified date | August 2019 |
Source | University of Alberta |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Babies born with hypoplastic left heart syndrome (HLHS) have three separate, complex heart
surgeries before they turn three years of age. The first surgery typically happens in the
first two weeks of life. After this operation, babies come back to the intensive care unit
with their chests open. Babies who have heart surgery retain body water after surgery and
this extra water slows recovery. Surgeons cannot close the chest until the baby gets rid of
the extra water. As a result, babies have to stay in the intensive care unit and on a
breathing machine for longer.
Peritoneal dialysis, also known as PD, involves placing a small catheter into the belly
cavity at the time of surgery. PD helps the kidney to get rid of extra body water. PD
involves putting small amounts of special fluid into the belly through the catheter. This
special fluid attracts water and is drained hourly. By allowing the belly cavity to drain,
this helps both the heart and the lungs. This allows the chest to be closed and the breathing
tube to be removed. The investigators are looking to see how quickly the babies, with and
without PD, get rid of the extra water in turn shortening their stay in the intensive care
unit and in the hospital. PD is not permanent, and only used for the first few days after the
operation.
Status | Completed |
Enrollment | 22 |
Est. completion date | December 2013 |
Est. primary completion date | October 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 30 Days |
Eligibility |
Inclusion Criteria: - Infants with HLHS or its variants who have a Norwood procedure - Parental consent Exclusion Criteria: - Premature neonates less than 37 weeks gestation - Weight less than 2 kg - Urine output less than 0.5ml/kg/hr over 24 hours in the 48 hours prior to the Norwood - Pre-operative renal replacement therapy - Abdominal defects precluding placement of a PD catheter - Known chromosomal abnormality - Pre-operative cardiopulmonary resuscitation (CPR) - Pre-operative extra-corporeal life support (ECLS) |
Country | Name | City | State |
---|---|---|---|
Canada | Stollery Children's Hospital | Edmonton | Alberta |
Lead Sponsor | Collaborator |
---|---|
University of Alberta | Women and Children's Health Research Institute, Canada |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to First Post-operative Negative 24 Hour Fluid Balance | Time to first post-operative negative fluid balance which occurred in first 72 hrs | up to 72 hours | |
Secondary | Time to Sternal Closure | Up to 200 hours | ||
Secondary | Time to Lactate Less Than or Equal to 2mmol/L | Time to lactate less than or equal to 2mmol/L typically occurred in first 24 hrs | From time of admission in PICU until assessment was reached, assessed up to 24 hours | |
Secondary | Time to First Extubation | Up to 15 days | ||
Secondary | Maximum Vasoactive Inotrope Score (VIS) on Post-operative Days 2-5 | The maximum VIS assessed from days 2-5 will be chosen. A total VIS score is reported; there are no subscales. Minimum VIS is 0 (there are no units to VIS). Maximum VIS could be 100 but numbers are more typically 5-40. Higher VIS represent more inotropic support and potentially worse outcomes. | Assessed at days 2, 3, 4 and 5 with the highest score from those 4 days reported | |
Secondary | Hospital Length of Stay | Assessed up to 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00513240 -
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00156455 -
Sleep Disordered Breathing in Children With Single Ventricle Physiology
|
N/A | |
Terminated |
NCT01445041 -
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01708863 -
A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
|
||
Completed |
NCT01736956 -
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
|
N/A | |
Recruiting |
NCT03406884 -
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
|
Phase 1 | |
Not yet recruiting |
NCT06461676 -
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)
|
Phase 1 | |
Active, not recruiting |
NCT03079401 -
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
|
Phase 1/Phase 2 | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Completed |
NCT01883076 -
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Completed |
NCT04056416 -
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
|
N/A | |
Completed |
NCT01656941 -
Genetic Determinants of Congenital Heart Disease Outcomes
|
||
Completed |
NCT00464100 -
Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
|
||
Active, not recruiting |
NCT03779711 -
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
|
Phase 2 | |
Recruiting |
NCT04925024 -
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
|
Phase 2 | |
Recruiting |
NCT02781922 -
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
|
Phase 3 | |
Completed |
NCT01582529 -
SVRII Family Factors Study
|
||
Completed |
NCT00974025 -
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
|
N/A |